{"transactions":[{"id":707410,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4147,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":75.53,"expiration_date":"2035-06-18","underlying":"Class A Common Stock","underlying_shares":4147},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707409,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4147,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":75.53,"expiration_date":"2035-06-18","underlying":"Class A Common Stock","underlying_shares":4147},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707408,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3789,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":80.03,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":3789},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707407,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3789,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":80.03,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":3789},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707406,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":44.68,"expiration_date":"2033-06-15","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707405,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":44.68,"expiration_date":"2033-06-15","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707404,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":9.36,"expiration_date":"2032-06-16","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707403,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":9.36,"expiration_date":"2032-06-16","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707402,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707401,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707400,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2717627,"price":124,"value":336985748.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2717627},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707399,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2717627,"price":124,"value":336985748.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2717627},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707398,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock - Restricted Stock Units","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3444,"price":124,"value":427056.0,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported shares of Class A Common Stock were issuable under restricted stock units (\"RSUs\") granted to Dr. Wheeler, which were held for the benefit, and at the direction, of Deerfield Management. Pursuant to the Merger Agreement, each of the reported RSUs was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such RSU immediately prior to the effective time of the Merger and (y) $124.00. The disposition or deemed disposition of such securities pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported shares of Class A Common Stock were issuable under restricted stock units (\"RSUs\") granted to Dr. Wheeler, which were held for the benefit, and at the direction, of Deerfield Management. Pursuant to the Merger Agreement, each of the reported RSUs was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such RSU immediately prior to the effective time of the Merger and (y) $124.00. The disposition or deemed disposition of such securities pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707397,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"other","planned":false,"acquired":false,"shares":5146,"price":124,"value":638104.0,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, on July 15, 2026, Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of the Issuer's Class A Common Stock and Class B Common Stock. The reported shares were tendered to, and accepted by, the Purchaser in exchange for the offer price of $124.00 per share, in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, on July 15, 2026, Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of the Issuer's Class A Common Stock and Class B Common Stock. The reported shares were tendered to, and accepted by, the Purchaser in exchange for the offer price of $124.00 per share, in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707396,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"other","planned":false,"acquired":false,"shares":5146,"price":124,"value":638104.0,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, on July 15, 2026, Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of the Issuer's Class A Common Stock and Class B Common Stock. The reported shares were tendered to, and accepted by, the Purchaser in exchange for the offer price of $124.00 per share, in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, on July 15, 2026, Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of the Issuer's Class A Common Stock and Class B Common Stock. The reported shares were tendered to, and accepted by, the Purchaser in exchange for the offer price of $124.00 per share, in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707395,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":650000,"price":124,"value":80600000.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707394,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8299225,"price":124,"value":1029103900.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707393,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8299225,"price":124,"value":1029103900.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":875272,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":5,"value":10000000.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6207982,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875271,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":831978,"price":5,"value":4159890.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8153107,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875270,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":1084012,"price":5,"value":5420060.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":10622957,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875269,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":1084010,"price":5,"value":5420050.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":10622928,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":990577,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2025-11-25T01:00:57.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":371287,"price":95.445,"value":35437487.715,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class A Common Stock were sold to underwriters pursuant to the exercise of the underwriters' option to purchase shares of Class A Common Stock from Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P., at a price per share of $95.445, to cover over-allotments in an underwritten public offering. The shares were sold to the public in the offering at a price of $101.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8299225,"source":{"system":"sec-edgar","filing":"0001193805-25-001648","document":"e665003_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001648/e665003_4-nuvl.xml","form_type":"4"}},{"id":990576,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2025-11-25T01:00:57.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":371287,"price":95.445,"value":35437487.715,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class A Common Stock were sold to underwriters pursuant to the exercise of the underwriters' option to purchase shares of Class A Common Stock from Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P., at a price per share of $95.445, to cover over-allotments in an underwritten public offering. The shares were sold to the public in the offering at a price of $101.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8299225,"source":{"system":"sec-edgar","filing":"0001193805-25-001648","document":"e665003_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001648/e665003_4-nuvl.xml","form_type":"4"}},{"id":1076729,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":2599932,"price":3.2,"value":8319782.4,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":7321129,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1076728,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":3387539,"price":3.2,"value":10840124.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":9538945,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1076727,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":3387529,"price":3.2,"value":10840092.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":9538918,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1098456,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-01T20:42:51.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":370074,"price":18.46,"value":6831566.04,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.20 to $18.89, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4887254,"source":{"system":"sec-edgar","filing":"0001193805-25-000959","document":"e664668_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000959/e664668_4-arsp.xml","form_type":"4"}},{"id":1098455,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-01T20:42:51.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":370075,"price":18.46,"value":6831584.5,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.20 to $18.89, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4887254,"source":{"system":"sec-edgar","filing":"0001193805-25-000959","document":"e664668_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000959/e664668_4-arsp.xml","form_type":"4"}},{"id":1367220,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":9553,"price":17.77,"value":169756.81,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.69 to $17.82, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5257328,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367219,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":9554,"price":17.77,"value":169774.58,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.69 to $17.82, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5257329,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367218,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":7854,"price":17.16,"value":134774.64,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.68 to $17.65, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5266881,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367217,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":7853,"price":17.16,"value":134757.48,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.68 to $17.65, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5266883,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367216,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":223632,"price":18.15,"value":4058920.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.51, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5274735,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367215,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":223632,"price":18.15,"value":4058920.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.51, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5274736,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367214,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":40596,"price":17.45,"value":708400.2,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.90 to $17.90, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 4, 5 and 6 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5498367,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1367213,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":4,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T01:16:26.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":40596,"price":17.45,"value":708400.2,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.90 to $17.90, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 4, 5 and 6 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":5498368,"source":{"system":"sec-edgar","filing":"0001193805-24-001348","document":"e664025_4-arsp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001348/e664025_4-arsp.xml","form_type":"4"}},{"id":1382126,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}}],"security":"Class A Common Stock","published_at":"2024-10-24T20:08:04.000Z","date":"2024-10-22","kind":"sale","planned":false,"acquired":false,"shares":1000000,"price":97.75,"value":97750000.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8670512,"source":{"system":"sec-edgar","filing":"0001193805-24-001275","document":"e663971_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001275/e663971_4-biomx.xml","form_type":"4"}},{"id":1382125,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}}],"security":"Class A Common Stock","published_at":"2024-10-24T20:08:04.000Z","date":"2024-10-22","kind":"sale","planned":false,"acquired":false,"shares":1000000,"price":97.75,"value":97750000.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8670512,"source":{"system":"sec-edgar","filing":"0001193805-24-001275","document":"e663971_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001275/e663971_4-biomx.xml","form_type":"4"}},{"id":1582150,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":4,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Class A Common Stock","published_at":"2024-03-12T23:01:39.000Z","date":"2024-03-12","kind":"sale","planned":false,"acquired":false,"shares":114906,"price":10.7,"value":1229494.2,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.69 to $10.70, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds or for the benefit of Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":11528863,"source":{"system":"sec-edgar","filing":"0001193805-24-000360","document":"e619363_4-ahcorp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000360/e619363_4-ahcorp.xml","form_type":"4"}},{"id":1582149,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":4,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Class A Common Stock","published_at":"2024-03-12T23:01:39.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":88040,"price":11.13,"value":979885.2,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.00 to $11.26, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds or for the benefit of Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":11643769,"source":{"system":"sec-edgar","filing":"0001193805-24-000360","document":"e619363_4-ahcorp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000360/e619363_4-ahcorp.xml","form_type":"4"}},{"id":1582148,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":4,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Class A Common Stock","published_at":"2024-03-12T23:01:39.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":94567,"price":10.92,"value":1032671.64,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.83 to $10.99, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds or for the benefit of Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":11731809,"source":{"system":"sec-edgar","filing":"0001193805-24-000360","document":"e619363_4-ahcorp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000360/e619363_4-ahcorp.xml","form_type":"4"}},{"id":1582147,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":4,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Class A Common Stock","published_at":"2024-03-12T23:01:39.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":4495,"price":11.03,"value":49579.85,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.00 to $11.04, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds or for the benefit of Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":11826376,"source":{"system":"sec-edgar","filing":"0001193805-24-000360","document":"e619363_4-ahcorp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000360/e619363_4-ahcorp.xml","form_type":"4"}},{"id":1582146,"issuer":{"id":5183,"kind":"organization","name":"AdaptHealth Corp.","symbol":"AHCO"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":4,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Class A Common Stock","published_at":"2024-03-12T23:01:39.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":47992,"price":10.92,"value":524072.64,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.85 to $10.99, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 4, 5, 6 and 7 of this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds or for the benefit of Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":11830871,"source":{"system":"sec-edgar","filing":"0001193805-24-000360","document":"e619363_4-ahcorp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000360/e619363_4-ahcorp.xml","form_type":"4"}},{"id":1639318,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430205,"price":8.74,"value":12499991.7,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4207982,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":1639317,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430206,"price":8.74,"value":12500000.44,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6151406,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":1639316,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430206,"price":8.74,"value":12500000.44,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6151389,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":2123703,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}}],"security":"Class A Common Stock","published_at":"2022-11-07T23:24:24.000Z","date":"2022-11-03","kind":"purchase","acquired":true,"shares":650000,"price":33.5,"value":21775000.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":650000,"source":{"system":"sec-edgar","filing":"0001193805-22-001493","document":"e617996_4-nuvalent.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001493/e617996_4-nuvalent.xml","form_type":"4"}},{"id":2154360,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2022-09-21T00:31:45.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2777777,"price":3.15,"value":8749997.55,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":2777777,"source":{"system":"sec-edgar","filing":"0001193805-22-001296","document":"e621937_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001296/e621937_4-larimar.xml","form_type":"4"}},{"id":2154359,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2022-09-21T00:31:45.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2777777,"price":3.15,"value":8749997.55,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4721197,"source":{"system":"sec-edgar","filing":"0001193805-22-001296","document":"e621937_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001296/e621937_4-larimar.xml","form_type":"4"}},{"id":2154358,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2022-09-21T00:31:45.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2777777,"price":3.15,"value":8749997.55,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4721200,"source":{"system":"sec-edgar","filing":"0001193805-22-001296","document":"e621937_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001296/e621937_4-larimar.xml","form_type":"4"}},{"id":2154357,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2022-09-21T00:31:45.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2777777,"price":3.15,"value":8749997.55,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4721183,"source":{"system":"sec-edgar","filing":"0001193805-22-001296","document":"e621937_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001296/e621937_4-larimar.xml","form_type":"4"}},{"id":2239420,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-06-08T23:25:31.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":6243,"price":24.47,"value":152766.21,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1540190,"source":{"system":"sec-edgar","filing":"0001193805-22-000932","document":"e621737_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522000932/e621737_4-mirum.xml","form_type":"4"}},{"id":2239419,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-06-08T23:25:31.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":6909,"price":24.47,"value":169063.23,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1704244,"source":{"system":"sec-edgar","filing":"0001193805-22-000932","document":"e621737_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522000932/e621737_4-mirum.xml","form_type":"4"}},{"id":2239418,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-06-08T23:25:31.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":155,"price":25.08,"value":3887.4,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1546433,"source":{"system":"sec-edgar","filing":"0001193805-22-000932","document":"e621737_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522000932/e621737_4-mirum.xml","form_type":"4"}},{"id":2239417,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-06-08T23:25:31.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":171,"price":25.08,"value":4288.68,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1711153,"source":{"system":"sec-edgar","filing":"0001193805-22-000932","document":"e621737_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522000932/e621737_4-mirum.xml","form_type":"4"}},{"id":2239416,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-06-08T23:25:31.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":11868,"price":25.29,"value":300141.72,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1546588,"source":{"system":"sec-edgar","filing":"0001193805-22-000932","document":"e621737_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522000932/e621737_4-mirum.xml","form_type":"4"}},{"id":2239415,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-06-08T23:25:31.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":13132,"price":25.29,"value":332108.28,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1711324,"source":{"system":"sec-edgar","filing":"0001193805-22-000932","document":"e621737_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522000932/e621737_4-mirum.xml","form_type":"4"}},{"id":2511593,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Public Warrants","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"other","acquired":true,"shares":625000,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":625000,"derivative":{"exercise_price":11.5,"exercise_date":"2021-12-12","expiration_date":"2026-11-12","underlying":"Class A Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511592,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Public Warrants","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"other","acquired":true,"shares":625000,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":625000,"derivative":{"exercise_price":11.5,"exercise_date":"2021-12-12","expiration_date":"2026-11-12","underlying":"Class A Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511591,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Private Placement Warrants","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"other","acquired":true,"shares":3177543,"ownership":{"direct":false,"nature":"Through DFP Sponsor, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Business Combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Business Combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Business Combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Business Combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":3177543,"derivative":{"exercise_price":11.5,"exercise_date":"2021-12-12","expiration_date":"2026-11-12","underlying":"Class A Common Stock","underlying_shares":3177543},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511590,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class B Common Stock","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":85113,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Through Deerfield Management Company, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Steven Hochberg, a partner in Deerfield Management, served as a director and the chief executive officer of the Issuer until his resignation from such positions on November 12, 2021 (prior to the vote of the Issuer's stockholders in respect of the consummation of the Issuer's initial business combination and prior to the transactions reported herein). The Class A Common Stock owned by Steven Hochberg and reported herein is held for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":85113},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511589,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class B Common Stock","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":40,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Through DFP Sponsor, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511588,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class B Common Stock","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"other","acquired":false,"shares":14887,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Through Deerfield Management Company, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"In connection with, and immediately prior to, the closing of the Issuer's initial business combination, pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, DFP Sponsor, LLC (the \"Sponsor\") forfeited 707,960 shares of Class B Common Stock and Steven Hochberg forfeited 14,887 shares of Class B Common Stock for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Steven Hochberg, a partner in Deerfield Management, served as a director and the chief executive officer of the Issuer until his resignation from such positions on November 12, 2021 (prior to the vote of the Issuer's stockholders in respect of the consummation of the Issuer's initial business combination and prior to the transactions reported herein). The Class A Common Stock owned by Steven Hochberg and reported herein is held for the benefit, and at the direction, of Deerfield Management."}],"balance_after":85113,"derivative":{"underlying":"Class A Common Stock","underlying_shares":14887},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511587,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class B Common Stock","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"other","acquired":false,"shares":707960,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Through DFP Sponsor, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"In connection with, and immediately prior to, the closing of the Issuer's initial business combination, pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, DFP Sponsor, LLC (the \"Sponsor\") forfeited 707,960 shares of Class B Common Stock and Steven Hochberg forfeited 14,887 shares of Class B Common Stock for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":40,"derivative":{"underlying":"Class A Common Stock","underlying_shares":707960},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511586,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Series A Common Stock Equivalent Convertible Preferred Stock","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"purchase","acquired":true,"shares":50000,"price":1000,"value":50000000.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of Class A Common Stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of Class A Common Stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of Class A Common Stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":58945,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511585,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Series A Common Stock Equivalent Convertible Preferred Stock","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"purchase","acquired":true,"shares":50000,"price":1000,"value":50000000.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of Class A Common Stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of Class A Common Stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Series A Common Stock Equivalent Convertible Preferred Stock (\"Common Equivalent Preferred Stock\") is convertible into 100 shares of Class A Common Stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) \"group\" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":58945,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511584,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class A Common Stock","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":85113,"ownership":{"direct":false,"nature":"Through Deerfield Management Company, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Steven Hochberg, a partner in Deerfield Management, served as a director and the chief executive officer of the Issuer until his resignation from such positions on November 12, 2021 (prior to the vote of the Issuer's stockholders in respect of the consummation of the Issuer's initial business combination and prior to the transactions reported herein). The Class A Common Stock owned by Steven Hochberg and reported herein is held for the benefit, and at the direction, of Deerfield Management."}],"balance_after":85113,"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2511583,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":2,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class A Common Stock","published_at":"2021-11-17T02:34:54.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":40,"ownership":{"direct":false,"nature":"Through DFP Sponsor, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\" and, together with Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. (\"Deerfield Management\") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the \"Sponsor\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":40,"source":{"system":"sec-edgar","filing":"0001193805-21-001590","document":"e621086_4-dfp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001590/e621086_4-dfp.xml","form_type":"4"}},{"id":2615859,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":300000,"price":17,"value":5100000.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":2717628,"derivative":{"underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615858,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":300000,"price":17,"value":5100000.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":2717628,"derivative":{"underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615857,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":2417628,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":2417628,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2417628},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615856,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":2417628,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Class B common stock does not have any voting rights (except in certain circumstances specified in the Issuer's certificate of incorporation) and is otherwise substantially equivalent to the Class A common stock. The Class B common stock is convertible into Class A common stock from time to time at the election of the holder, except that conversion is prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A common stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A common stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":2417628,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2417628},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615855,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Series B Preferred Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":4831384,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":897671},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615854,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Series B Preferred Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":4831384,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":897671},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615853,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Series A Preferred Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":13011988,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":2417628},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615852,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Series A Preferred Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":13011988,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":2417628},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615851,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Series A Preferred Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":45716568,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":13011988,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8494140},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615850,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Series A Preferred Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":45716568,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":13011988,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8494140},"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615849,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":897671,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":9670511,"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615848,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":897671,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock held by each Fund automatically converted into approximately 0.18580 shares of the Issuer's Class A common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":9670511,"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615847,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":8494140,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8772840,"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2615846,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2021-08-04T22:05:04.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":8494140,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock held by each Fund (as defined below) automatically converted into either (i) approximately 0.18580 shares of the Issuer's Class A common stock or (ii) at the election of such Fund, approximately 0.18580 shares of the Issuer's Class B common stock. Each Fund elected to have 2,417,628 shares of common stock issuable to such Fund upon conversion of its Series A Preferred Stock issued in the form of Class B common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8772840,"source":{"system":"sec-edgar","filing":"0001193805-21-001101","document":"e620838_4-nuvalent.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001101/e620838_4-nuvalent.xml","form_type":"4"}},{"id":2635343,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":7,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":137394,"kind":"organization","name":"Deerfield Special Situations Fund, L.P.","position":8,"cik":"0001354395","reported_name":"Deerfield Special Situations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-07-13T16:06:20.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":99325,"price":15.81,"value":1570328.25,"ownership":{"direct":false,"nature":"Through Deerfield Special Situations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.81 to $15.91, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. (\"Deerfield Special Situations\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV and Deerfield Special Situations, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-21-001014","document":"e620792_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521001014/e620792_4-mirum.xml","form_type":"4"}},{"id":2639990,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":7,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":137394,"kind":"organization","name":"Deerfield Special Situations Fund, L.P.","position":8,"cik":"0001354395","reported_name":"Deerfield Special Situations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-07-07T22:48:32.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":6837,"price":15.869,"value":108496.353,"ownership":{"direct":false,"nature":"Through Deerfield Special Situations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.84 to $15.955, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. (\"Deerfield Special Situations\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV and Deerfield Special Situations, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":99325,"source":{"system":"sec-edgar","filing":"0001193805-21-000999","document":"e620783_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000999/e620783_4-mirum.xml","form_type":"4"}},{"id":2639989,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":7,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":137394,"kind":"organization","name":"Deerfield Special Situations Fund, L.P.","position":8,"cik":"0001354395","reported_name":"Deerfield Special Situations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-07-07T22:48:32.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":49239,"price":16.195,"value":797425.605,"ownership":{"direct":false,"nature":"Through Deerfield Special Situations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.185 to $16.345, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. (\"Deerfield Special Situations\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV and Deerfield Special Situations, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":106162,"source":{"system":"sec-edgar","filing":"0001193805-21-000999","document":"e620783_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000999/e620783_4-mirum.xml","form_type":"4"}},{"id":2639988,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":3,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":4,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":5,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":6,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":7,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}},{"id":137394,"kind":"organization","name":"Deerfield Special Situations Fund, L.P.","position":8,"cik":"0001354395","reported_name":"Deerfield Special Situations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-07-07T22:48:32.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":10599,"price":17.011,"value":180299.589,"ownership":{"direct":false,"nature":"Through Deerfield Special Situations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.85 to $17.55, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. (\"Deerfield Special Situations\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund IV and Deerfield Special Situations, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":155401,"source":{"system":"sec-edgar","filing":"0001193805-21-000999","document":"e620783_4-mirum.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000999/e620783_4-mirum.xml","form_type":"4"}},{"id":2645846,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2021-07-02T21:07:18.000Z","date":"2021-06-30","kind":"purchase","acquired":true,"shares":228570,"price":8.75,"value":1999987.5,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares reported herein as being held through Deerfield Private Design Fund III, L.P. (\"Fund III\"), Deerfield Private Design Fund IV, L.P. (\"Fund IV\") and Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\" and, collectively with Fund III and Fund IV, the \"Funds\") include shares that were previously reported as being held indirectly through Chondrial Therapeutics Holdings, LLC (\"Chondrial\"), which shares were distributed to the Funds pursuant to a pro rata distribution to the members of Chondrial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Fund III. Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt HIF, L.P. is the general partner of Deerfield HIF. Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1943420,"source":{"system":"sec-edgar","filing":"0001193805-21-000974","document":"e620772_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000974/e620772_4-larimar.xml","form_type":"4"}},{"id":2645845,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2021-07-02T21:07:18.000Z","date":"2021-06-30","kind":"purchase","acquired":true,"shares":228571,"price":8.75,"value":1999996.25,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares reported herein as being held through Deerfield Private Design Fund III, L.P. (\"Fund III\"), Deerfield Private Design Fund IV, L.P. (\"Fund IV\") and Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\" and, collectively with Fund III and Fund IV, the \"Funds\") include shares that were previously reported as being held indirectly through Chondrial Therapeutics Holdings, LLC (\"Chondrial\"), which shares were distributed to the Funds pursuant to a pro rata distribution to the members of Chondrial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Fund III. Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt HIF, L.P. is the general partner of Deerfield HIF. Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1943423,"source":{"system":"sec-edgar","filing":"0001193805-21-000974","document":"e620772_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000974/e620772_4-larimar.xml","form_type":"4"}},{"id":2645844,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":7,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2021-07-02T21:07:18.000Z","date":"2021-06-30","kind":"purchase","acquired":true,"shares":228569,"price":8.75,"value":1999978.75,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares reported herein as being held through Deerfield Private Design Fund III, L.P. (\"Fund III\"), Deerfield Private Design Fund IV, L.P. (\"Fund IV\") and Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\" and, collectively with Fund III and Fund IV, the \"Funds\") include shares that were previously reported as being held indirectly through Chondrial Therapeutics Holdings, LLC (\"Chondrial\"), which shares were distributed to the Funds pursuant to a pro rata distribution to the members of Chondrial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Fund III. Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt HIF, L.P. is the general partner of Deerfield HIF. Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1943406,"source":{"system":"sec-edgar","filing":"0001193805-21-000974","document":"e620772_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000974/e620772_4-larimar.xml","form_type":"4"}},{"id":2684416,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":4,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"6% Convertible Note due 2023","published_at":"2021-06-03T21:04:17.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"reported_value":10000000,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The 6% Convertible Note due 2023 held by Deerfield Partners, L.P. (\"Deerfield Partners\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The 6% Convertible Note due 2023 held by Deerfield Partners, L.P. (\"Deerfield Partners\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The 6% Convertible Note due 2023 held by Deerfield Partners, L.P. (\"Deerfield Partners\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The 6% Convertible Note due 2023 held by Deerfield Partners, L.P. (\"Deerfield Partners\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"exercise_price":17.6,"underlying":"Common Stock","underlying_shares":577148},"source":{"system":"sec-edgar","filing":"0001193805-21-000800","document":"e620679_4-sgs.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000800/e620679_4-sgs.xml","form_type":"4"}},{"id":2684415,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":4,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"6% Convertible Note due 2023","published_at":"2021-06-03T21:04:17.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"reported_value":10000000,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The 6% Convertible Note due 2023 held by Deerfield Private Design Fund IV, L.P. (\"Fund IV\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The 6% Convertible Note due 2023 held by Deerfield Private Design Fund IV, L.P. (\"Fund IV\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The 6% Convertible Note due 2023 held by Deerfield Private Design Fund IV, L.P. (\"Fund IV\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The 6% Convertible Note due 2023 held by Deerfield Private Design Fund IV, L.P. (\"Fund IV\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"exercise_price":17.6,"underlying":"Common Stock","underlying_shares":577148},"source":{"system":"sec-edgar","filing":"0001193805-21-000800","document":"e620679_4-sgs.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000800/e620679_4-sgs.xml","form_type":"4"}},{"id":2684414,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":4,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Series B Preferred Stock","published_at":"2021-06-03T21:04:17.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":6457723,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6457723},"source":{"system":"sec-edgar","filing":"0001193805-21-000800","document":"e620679_4-sgs.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000800/e620679_4-sgs.xml","form_type":"4"}},{"id":2684413,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":4,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-06-03T21:04:17.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":1050000,"price":22,"value":23100000.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1627148,"source":{"system":"sec-edgar","filing":"0001193805-21-000800","document":"e620679_4-sgs.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000800/e620679_4-sgs.xml","form_type":"4"}},{"id":2684412,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":4,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-06-03T21:04:17.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":450000,"price":22,"value":9900000.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":7484871,"source":{"system":"sec-edgar","filing":"0001193805-21-000800","document":"e620679_4-sgs.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000800/e620679_4-sgs.xml","form_type":"4"}},{"id":2684411,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":4,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-06-03T21:04:17.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":577148,"price":17.6,"value":10157804.8,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The 6% Convertible Note due 2023 held by Deerfield Partners, L.P. (\"Deerfield Partners\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":577148,"source":{"system":"sec-edgar","filing":"0001193805-21-000800","document":"e620679_4-sgs.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000800/e620679_4-sgs.xml","form_type":"4"}},{"id":2684410,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":4,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-06-03T21:04:17.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":577148,"price":17.6,"value":10157804.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The 6% Convertible Note due 2023 held by Deerfield Private Design Fund IV, L.P. (\"Fund IV\") automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":7034871,"source":{"system":"sec-edgar","filing":"0001193805-21-000800","document":"e620679_4-sgs.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000800/e620679_4-sgs.xml","form_type":"4"}},{"id":2684409,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":3,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":4,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":6,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2021-06-03T21:04:17.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":6457723,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Fund IV. Deerfield Mgmt, L.P. is the general partner of Deerfield Partners (collectively with Fund IV, the \"Funds\"). Deerfield Management is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6457723,"source":{"system":"sec-edgar","filing":"0001193805-21-000800","document":"e620679_4-sgs.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000800/e620679_4-sgs.xml","form_type":"4"}},{"id":2768477,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":2,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":4,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series C Preferred Stock","published_at":"2021-03-30T19:42:58.000Z","date":"2021-03-30","kind":"exercise","acquired":false,"shares":433551,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series C Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to the 1-for-1.8932 reverse split of the Issuer's common stock effected by the Issuer on March 19, 2021 in connection with its initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to the 1-for-1.8932 reverse split of the Issuer's common stock effected by the Issuer on March 19, 2021 in connection with its initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to the 1-for-1.8932 reverse split of the Issuer's common stock effected by the Issuer on March 19, 2021 in connection with its initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to the 1-for-1.8932 reverse split of the Issuer's common stock effected by the Issuer on March 19, 2021 in connection with its initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (the \"Fund\"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":433551},"source":{"system":"sec-edgar","filing":"0001193805-21-000435","document":"e620431_4-et.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000435/e620431_4-et.xml","form_type":"4"}},{"id":2768476,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":2,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":4,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series B-2 Preferred Stock","published_at":"2021-03-30T19:42:58.000Z","date":"2021-03-30","kind":"exercise","acquired":false,"shares":1301626,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series B-2 Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to the 1-for-1.8932 reverse split of the Issuer's common stock effected by the Issuer on March 19, 2021 in connection with its initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to the 1-for-1.8932 reverse split of the Issuer's common stock effected by the Issuer on March 19, 2021 in connection with its initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to the 1-for-1.8932 reverse split of the Issuer's common stock effected by the Issuer on March 19, 2021 in connection with its initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 Preferred Stock automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to the 1-for-1.8932 reverse split of the Issuer's common stock effected by the Issuer on March 19, 2021 in connection with its initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (the \"Fund\"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1301626},"source":{"system":"sec-edgar","filing":"0001193805-21-000435","document":"e620431_4-et.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380521000435/e620431_4-et.xml","form_type":"4"}}],"next_cursor":"2021-03-30T19:42:58.000000Z,2768476"}